Literature DB >> 8729666

Diminution of T cells with gamma delta receptor in the peripheral blood of allergic asthmatic individuals.

K S Chen1, K H Miller, D Hengehold.   

Abstract

BACKGROUND: T cells are shown to regulate allergy and asthma. They are heterogeneous by virtue of surface receptor subtypes (alpha beta and gamma delta receptors), however, their pathophysiological roles in asthma are unclear. OBJECTIVE AND METHODS: The present study employed flow cytometric analysis to compare the size of T-cell subsets and eosinophils present in the peripheral blood of healthy, allergic and allergic asthmatic individuals.
RESULTS: Current results demonstrated that the percentages of gamma delta T cells declined from 4.1% in healthy to 3.2% in the allergic subjects and to a significantly lower (P = 0.01) 2.4% in allergic asthmatics. The absolute numbers of circulating gamma delta T cells also were diminished in a similar fashion such that healthy individuals had a significantly higher mean cell count (91.8 x 10(3)/mL) than did allergic asthmatics (47.8 x 10(3)/mL) (P = 0.0266). In contrast, alpha beta T cells were comparable in the healthy, allergic, and allergic asthmatic populations (65.3%, 65.8% and 69.4%, respectively); the differences were not statistically significant. On a populational basis, the proportion of individuals having both gamma delta T cells < or = 4.1% and eosinophils > or = 2.1% was the lowest in the healthy population (30.8%), but was elevated in the allergic group (85.7%) as well as in the allergic asthmatic group (86.6%). However, on an individual basis, those who had reduced gamma delta T cells did not have consistently higher eosinophil counts or IgE level.
CONCLUSION: It was concluded that no significant correlation existed between the levels between gamma delta T cells and eosinophils or between gamma delta T cells and IgE present in the peripheral blood. This report, for the first time, documents that allergic asthmatics have reduced gamma delta T cells with reciprocally elevated eosinophil numbers in their peripheral circulation. However, it does not indicate that the reduction of gamma delta T cells directly correlates with the predominance of eosinophils of IgE levels in the diseased populations. The pathophysiological role of gamma delta T cells in allergic diseases awaits further exploration.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8729666

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  7 in total

Review 1.  gamma delta T cells in autoimmunity.

Authors:  Z Yin; J Craft
Journal:  Springer Semin Immunopathol       Date:  2000

Review 2.  The role of regulatory T cells in allergy.

Authors:  Maria A Curotto de Lafaille; Juan J Lafaille
Journal:  Springer Semin Immunopathol       Date:  2003-10-22

Review 3.  Quantitative peripheral blood perturbations of γδ T cells in human disease and their clinical implications.

Authors:  Ilan Bank; Victoria Marcu-Malina
Journal:  Clin Rev Allergy Immunol       Date:  2014-12       Impact factor: 8.667

4.  Analysis of circulating gammadelta T cells in children affected by IgE-associated and non-IgE-associated allergic atopic eczema/dermatitis syndrome.

Authors:  C Cairo; E Arabito; F Landi; A Casati; E Brunetti; G Mancino; E Galli
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

5.  Changes in T-cell receptor subsets after cardiac surgery in children.

Authors:  T Yamaguchi; A Murakami; K Fukahara; T Ueda; F Ichida; T Miyawaki; T Misaki
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

6.  Gamma delta T cells in non-immune patients during primary schistosomal infection.

Authors:  Eli Schwartz; Etti Rosenthal; Ilan Bank
Journal:  Immun Inflamm Dis       Date:  2014-05-16

Review 7.  γδ T Lymphocytes in Asthma: a Complicated Picture.

Authors:  Michał K Zarobkiewicz; Ewelina Wawryk-Gawda; Wioleta Kowalska; Mariola Janiszewska; Agnieszka Bojarska-Junak
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2021-03-04       Impact factor: 4.291

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.